Read More Apparatus Another Cancer-Independent Targeted Drug Approved! Up To 84% Efficacy! Apr 08, 2025
Read More Medical More Significant Survival Benefit For Non-Small Cell Lung Cancer Patients Under 55 Years Of Age, Also Using Immunotherapy! Apr 17, 2025
Read More Apparatus Heavyweight! First ADC Drug For Refractory Ovarian Cancer Receives Accelerated FDA Approval Mar 31, 2025
